FDA moves to lift ‘black box’ warnings from hormone therapies for menopause symptoms
The U.S. Food and Drug Administration (FDA) announced it is initiating the removal of ‘black box’ warning labels from hormone replacement therapy (HRT) products used to ease menopause symptoms, a move Commissioner Dr. Marty Makary said is backed by decades of research on the therapy’s benefits and clinical trials that do not support earlier fears
